Histopathologic review of 400 biopsies and resection specimens of trunk and extremity-based soft tissue tumors

Indian Journal of Cancer
R BadanaleA Puri

Abstract

To review various pathologic parameters in diagnosed cases of trunk and extremity-based soft tissue tumors (STTs), in order to identify concordance rate between initial biopsy and resection specimen and discrepancies between initial and review diagnosis, by a specialist pathologist. Over a 2-year-period, 400 retrospectively diagnosed STTs (553 specimens) including referral and "in-house" cases were studied. The reviewing specialist pathologist was blinded to the initial diagnoses. Discordances including discrepancies and deficiencies were defined as major and minor. Major discrepancies included those that could lead to significant treatment changes. True discrepancies were those related to sampling issues between the biopsies and resection specimens. Deficiencies relating to tumor subtyping, sarcoma grading, documentation of tumor size, and marginal status (in resections) were subdivided as major and minor. Most cases (328, 82%) were sarcomas (most common, synovial sarcoma; most common Stage, III), followed by benign tumors (36, 9%) (most common, schwannoma) and intermediate malignancies (32, 8%) (most common, fibromatosis). Within STTs, liposarcomas, neural tumors, and undifferentiated pleomorphic sarcomas were relatively more...Continue Reading

References

Dec 1, 1991·British Journal of Cancer·A L HartleyL J McWilliam
Jul 1, 1990·The British Journal of Surgery·A B BallG Westbury
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A Alvegård, N O Berg
Sep 1, 1988·The Australian and New Zealand Journal of Surgery·M F Brennan
Sep 1, 1986·The British Journal of Surgery·M W KissinG Westbury
Mar 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D A PotterS A Rosenberg
Mar 1, 1995·Journal of Clinical Pathology·R J PrescottM Harris
Jan 1, 1995·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·J M Thomas
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W PistersM F Brennan
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L GuillouJ Costa
Oct 17, 2001·American Journal of Clinical Pathology·Z K ArbiserS W Weiss
Feb 5, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Ray-CoquardJ-Y Blay
Dec 20, 2005·Histopathology·A P Dei Tos
Jul 17, 2010·Sarcoma·Robert GrimerBeatrice Seddon
Feb 15, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Ray-CoquardJ Y Blay
Apr 29, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bharat Rekhi, Ulrich Vogel
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I Ray-CoquardJ Y Blay

❮ Previous
Next ❯

Citations

Aug 28, 2020·Cytopathology : Official Journal of the British Society for Clinical Cytology·Bharat RekhiMukta Ramadwar
Jan 1, 2022·Pediatric Blood & Cancer·Sharada MailankodyJyoti Bajpai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.